康鹏科技 (688602)
Shanghai Chemspec Corporation
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 51937.50
- Circulating A-Shares(W): 25959.62
- Earnings Per Share(RMB): -0.0100
- Net Assets Per Share(RMB): 5.3725
- Operating Revenue(W RMB): 59617.52
- Total Profit(W RMB): -801.25
- **Net Profit Attributable to Parent(W RMB) **: -395.00
- Net Profit Growth Rate(%): 77.23
- Weighted Return on Equity(%): -0.1400
- Operating Cash Flow Per Share(RMB): 0.2520
- Undistributed Profit Per Share(RMB): 1.2835
- Capital Reserve Per Share(RMB): 2.9887
2. Main Business
The main business covers:
- Research, development, production, and sales of fine chemicals
3. Company Basic Information
- Company Name: Shanghai Chemspec Corporation
- Listing Date: 2023-07-20
- Industry: Chemical Raw Materials and Chemical Products Manufacturing
- Address: Building 1, No. 200, Lane 2891, Qilianshan South Road, Putuo District, Shanghai
- Website: https://www.chemspec.com.cn
- Company Profile: The issuer is a joint stock company established through the overall transformation of Chemspec Limited. On January 21, 2019, the promoters jointly signed the "Sponsor Agreement." Based on the audited net assets of Chemspec Limited as of November 30, 2018, which amounted to RMB 727.7695 million, the company converted the net assets at a ratio of 1:0.4947 into share capital of RMB 360,000,000.00. The remaining balance of the net assets was included in the company's capital reserve. The company's name was changed to "Shanghai Chemspec Corporation." On March 21, 2019, the Shanghai Market Supervision and Administration Bureau approved the company's change application and issued the "Business License" for Shanghai Chemspec Corporation. On March 28, 2019, KPMG issued the "Capital Verification Report" (KPMG Huazhen Verification No. 1900191), confirming that as of March 21, 2019, the company had received a total registered capital of RMB 360 million from all shareholders, contributed in the form of the net assets of Chemspec Limited as of November 30, 2018. (Unified Social Credit Code: 91310000632043877H).
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Wuxi Yunhui New Automotive Industry Investment Management Partnership (Limited Partnership) - Beijing Yunhui Private Fund Management Co., Ltd. | General Legal Person | 2106.71 | 8.12 |
| 2 | Hunan Zhongqi Dongjian Private Equity Investment Partnership (Limited Partnership) | General Legal Person | 1011.40 | 3.90 |
| 3 | Tongxiang Jiawo Yunfeng Equity Investment Partnership (Limited Partnership) | General Legal Person | 762.73 | 2.94 |
| 4 | Tongxiang Yunhui Equity Investment Fund Partnership (Limited Partnership) | General Legal Person | 739.10 | 2.85 |
| 5 | Suzhou Shangkai Venture Capital Partnership (Limited Partnership) - Ningbo Bonded Zone Jiaxin Qiyue Equity Investment Management Co., Ltd. | General Legal Person | 525.00 | 2.02 |
| 6 | Suzhou Jinlin Venture Capital Partnership (Limited Partnership) - Shanghai Runzhang Venture Capital Management Co., Ltd. | Asset Management Plan | 525.00 | 2.02 |
| 7 | CITIC Securities - Bank of China - CITIC Securities Stock Butler Chemspec No. 1 Science and Technology Innovation Board Strategic Placement Collective Asset Management Plan | Asset Management Plan | 510.63 | 1.97 |
| 8 | Shenzhen Jiaqiao Fukai No. 16 Venture Capital Enterprise (Limited Partnership) - Shenzhen Jiaqiao Fukai Private Venture Capital Fund Management Co., Ltd. | Asset Management Plan | 510.00 | 1.96 |
| 9 | Ningbo Meishan Bonded Port Area Xingyu Huitian Investment Management Partnership (Limited Partnership) | General Legal Person | 490.17 | 1.89 |
| 10 | Suzhou Cathay Growth Investment Fund Partnership (Limited Partnership) - Cathay (Quanzhou) Private Fund Management Co., Ltd. | General Legal Person | 440.80 | 1.70 |
5. Concept Sectors
- Lithium Battery
- OLED Concept
- Lithography Machine
- Super Capacitor
- Organic Silicon
- CXO Concept
- New Materials
- Solid-State Battery
- Weight Loss Drugs
Remarks
- Data update date: 2025-09-30
- Data source: Public market information
